JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farah, A.
Right arrow Articles by Frazer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farah, A.
Right arrow Articles by Frazer, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 145, Issue 2, 187-193, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE RATE OF RUNOUT OF N-METHYLNICOTINAMIDE FROM DOG RENAL SLICES

A. Farah 1 and M. Frazer 1

1 Department of Pharmacology, State University of New York, Update Medical Center, Syracuse, New York

The runout of N-methylnicotinamide from dog renal slices has been studied and compared with that of p-aminohippurate. N-Methylnicotinamide runout is not influenced by metabolic inhibitors such as dinitrophenol, iodoacetate and cyanide in concentrations which completely inhibit uptake of N-methylnicotinamide by dog renal slices. The competitive inhibitors, cyanine dye 863 and mepiperphenidol (Darstine) produce a partial reduction of the rate of runout of N-methylnicotinamide in concentrations which inibit uptake completely. Tolazoline (Priscoline) has minimal while tetraethylammonium has no effect on the rate of runout of N-methylnicotin-amide in concentrations which inhibit its uptake completely. These results have been compared and contrasted with those obtained previously with p-aminohippurate and it is concluded that in the N-methylnicotinamide system counter transport cannot be demonstrated. The runout of NMN probably has a passive component uninfluenced by inhibitors and a second component which is carrier mediated.

Accepted on April 10, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.